These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 18032110
1. Drugs acting on SUR1 to treat CNS ischemia and trauma. Simard JM, Woo SK, Bhatta S, Gerzanich V. Curr Opin Pharmacol; 2008 Feb; 8(1):42-9. PubMed ID: 18032110 [Abstract] [Full Text] [Related]
2. A cytosolic factor that inhibits KATP channels expressed in Xenopus oocytes by impairing Mg-nucleotide activation by SUR1. Tammaro P, Ashcroft FM. J Physiol; 2009 Apr 15; 587(Pt 8):1649-56. PubMed ID: 19237428 [Abstract] [Full Text] [Related]
3. Does inhibiting Sur1 complement rt-PA in cerebral ischemia? Simard JM, Geng Z, Silver FL, Sheth KN, Kimberly WT, Stern BJ, Colucci M, Gerzanich V. Ann N Y Acad Sci; 2012 Sep 15; 1268():95-107. PubMed ID: 22994227 [Abstract] [Full Text] [Related]
4. Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T). Hambrock A, de Oliveira Franz CB, Hiller S, Osswald H. J Pharmacol Exp Ther; 2006 Mar 15; 316(3):1031-7. PubMed ID: 16306272 [Abstract] [Full Text] [Related]
5. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. Chen M, Dong Y, Simard JM. J Neurosci; 2003 Sep 17; 23(24):8568-77. PubMed ID: 13679426 [Abstract] [Full Text] [Related]
6. The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel. Woo SK, Kwon MS, Ivanov A, Gerzanich V, Simard JM. J Biol Chem; 2013 Feb 01; 288(5):3655-67. PubMed ID: 23255597 [Abstract] [Full Text] [Related]
7. Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury. Elrod JW, Harrell M, Flagg TP, Gundewar S, Magnuson MA, Nichols CG, Coetzee WA, Lefer DJ. Circulation; 2008 Mar 18; 117(11):1405-13. PubMed ID: 18316485 [Abstract] [Full Text] [Related]
9. Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. Simard JM, Tsymbalyuk O, Ivanov A, Ivanova S, Bhatta S, Geng Z, Woo SK, Gerzanich V. J Clin Invest; 2007 Aug 18; 117(8):2105-13. PubMed ID: 17657312 [Abstract] [Full Text] [Related]
10. Sulfonylurea receptor 1 in central nervous system injury: a focused review. Simard JM, Woo SK, Schwartzbauer GT, Gerzanich V. J Cereb Blood Flow Metab; 2012 Sep 18; 32(9):1699-717. PubMed ID: 22714048 [Abstract] [Full Text] [Related]
11. The antiarrhythmic agent cibenzoline inhibits KATP channels by binding to Kir6.2. Mukai E, Ishida H, Horie M, Noma A, Seino Y, Takano M. Biochem Biophys Res Commun; 1998 Oct 20; 251(2):477-81. PubMed ID: 9792799 [Abstract] [Full Text] [Related]
12. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure. Dörschner H, Brekardin E, Uhde I, Schwanstecher C, Schwanstecher M. Mol Pharmacol; 1999 Jun 20; 55(6):1060-6. PubMed ID: 10347249 [Abstract] [Full Text] [Related]
13. [Ontogeny of sulphonylurea-binding regulatory subunits of K(ATP) channels in the pregnant rat myometrium]. Lovász N, Ducza E, Gáspár R, Falkay G. Acta Pharm Hung; 2011 Jun 20; 81(3):101-7. PubMed ID: 22165413 [Abstract] [Full Text] [Related]
14. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Simard JM, Chen M, Tarasov KV, Bhatta S, Ivanova S, Melnitchenko L, Tsymbalyuk N, West GA, Gerzanich V. Nat Med; 2006 Apr 20; 12(4):433-40. PubMed ID: 16550187 [Abstract] [Full Text] [Related]
15. MgADP antagonism to Mg2+-independent ATP binding of the sulfonylurea receptor SUR1. Ueda K, Inagaki N, Seino S. J Biol Chem; 1997 Sep 12; 272(37):22983-6. PubMed ID: 9287292 [Abstract] [Full Text] [Related]
16. Ontogeny of sulfonylurea-binding regulatory subunits of K(ATP) channels in the pregnant rat myometrium. Lovasz N, Ducza E, Gaspar R, Falkay G. Reproduction; 2011 Jul 12; 142(1):175-81. PubMed ID: 21527399 [Abstract] [Full Text] [Related]
17. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A. Cui Y, Tinker A, Clapp LH. Br J Pharmacol; 2003 May 12; 139(1):122-8. PubMed ID: 12746230 [Abstract] [Full Text] [Related]
19. [Molecular and functional diversity of ATP-sensitive K+ channels: the pathophysiological roles and potential drug targets]. Nakaya H, Miki T, Seino S, Yamada K, Inagaki N, Suzuki M, Sato T, Yamada M, Matsushita K, Kurachi Y, Arita M. Nihon Yakurigaku Zasshi; 2003 Sep 05; 122(3):243-50. PubMed ID: 12939542 [Abstract] [Full Text] [Related]